The data shown was taken in each case from the latest announcement communicated by the shareholder.
|Release according to § 21 Abs. 1 WpHG:|
|89.88%||Tiancheng (Germany) Pharmaceutical Holdings AG (acquisition company of the Creat Group Corporation)|
|4.99%||JO Hambro Capital Management Ltd, London, UK|